G‐protein‐coupled receptors: past, present and future

The G‐protein‐coupled receptor (GPCR) family represents the largest and most versatile group of cell surface receptors. Drugs active at these receptors have therapeutic actions across a wide range of human diseases ranging from allergic rhinitis to pain, hypertension and schizophrenia. This review provides a brief historical overview of the properties and signalling characteristics of this important family of receptors.

[1]  I. Hall,et al.  Pharmacological characterization of CGP 12177 at the human β2‐adrenoceptor , 2002 .

[2]  A. De Léan,et al.  The ternary complex model. Its properties and application to ligand interactions with the D2-dopamine receptor of the anterior pituitary gland. , 1984, Molecular pharmacology.

[3]  A. Engel,et al.  Atomic-force microscopy: Rhodopsin dimers in native disc membranes , 2003, Nature.

[4]  P. Insel,et al.  The evolving role of lipid rafts and caveolae in G protein‐coupled receptor signaling: implications for molecular pharmacology , 2004, British journal of pharmacology.

[5]  A Herz,et al.  Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Iain D.C. Fraser,et al.  Assembly of an A kinase-anchoring protein–β2-adrenergic receptor complex facilitates receptor phosphorylation and signaling , 2000, Current Biology.

[7]  Krzysztof Palczewski,et al.  Rhodopsin dimers in native disc membranes: Neat rows of paired photon receptors are caught on camera in their natural state , 2003 .

[8]  J. Daly,et al.  Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Berridge,et al.  Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. , 1982, The Biochemical journal.

[10]  Alan Wise,et al.  The identification of ligands at orphan G-protein coupled receptors. , 2004, Annual review of pharmacology and toxicology.

[11]  O. ARUNLAKSHANA,et al.  SOME QUANTITATIVE USES OF DRUG ANTAGONISTS , 1997, British journal of pharmacology and chemotherapy.

[12]  R P STEPHENSON,et al.  A MODIFICATION OF RECEPTOR THEORY , 1997, British journal of pharmacology and chemotherapy.

[13]  N. Birdsall,et al.  Ligand-binding propeties of the muscarinic acetylcholine receptor in mouse neuroblastoma cells. , 1978, The Biochemical journal.

[14]  Michel Bouvier,et al.  A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation* , 1996, The Journal of Biological Chemistry.

[15]  S. Shenolikar,et al.  The β2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange , 1998, Nature.

[16]  T. Kenakin,et al.  G Protein-Coupled Receptor Allosterism and Complexing , 2002, Pharmacological Reviews.

[17]  S. Shenolikar,et al.  The b 2-adrenergic receptor interactswith the Na + / H +-exchanger regulatory factor tocontrol Na + / H + exchange , 2022 .

[18]  G. Milligan,et al.  Coordinated agonist regulation of receptor and G protein palmitoylation and functional rescue of palmitoylation-deficient mutants of the G protein G11alpha following fusion to the alpha1b-adrenoreceptor: palmitoylation of G11alpha is not required for interaction with beta*gamma complex. , 2001, The Journal of biological chemistry.

[19]  H. Rang,et al.  The uptake of atropine and related drugs by intestinal smooth muscle of the guinea-pig in relation to acetylcholine receptors , 1965, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[20]  Willem Soudijn,et al.  Allosteric modulation of G protein-coupled receptors: perspectives and recent developments. , 2004, Drug discovery today.

[21]  R. Lefkowitz,et al.  A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. , 1980, The Journal of biological chemistry.

[22]  J. Wess,et al.  Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Daly,et al.  Guanosine 5'-(beta, gamma-imido)triphosphate inhibition of forskolin-activated adenylate cyclase is mediated by the putative inhibitory guanine nucleotide regulatory protein. , 1982, The Journal of biological chemistry.

[24]  R. Tsien,et al.  A new generation of Ca2+ indicators with greatly improved fluorescence properties. , 1985, The Journal of biological chemistry.

[25]  J. Young,et al.  THE BINDING OF [3H]‐PROPYLBENZILYLCHOLINE MUSTARD BY LONGITUDINAL MUSCLE STRIPS FROM GUINEA‐PIG SMALL INTESTINE , 1974 .

[26]  R. Neubig,et al.  AT1 Receptor Mutant Lacking Heterotrimeric G Protein Coupling Activates the Src-Ras-ERK Pathway without Nuclear Translocation of ERKs* , 2002, The Journal of Biological Chemistry.

[27]  Pascale G. Charest,et al.  Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Joseph Parello,et al.  Structure-based analysis of GPCR function: evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. , 2003, Journal of molecular biology.

[29]  R. Lefkowitz,et al.  Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. , 1993, Trends in pharmacological sciences.

[30]  M. W. George,et al.  Quantitative analysis of the formation and diffusion of A1-adenosine receptor-antagonist complexes in single living cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[31]  S. Nahorski.  Altered responsiveness of cerebral beta adrenoceptors assessed by adenosine cyclic 3',5'-monophosphate formation and (3H)propranolol binding. , 1977, Molecular pharmacology.

[32]  Michel Bouvier,et al.  Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. , 2005, Trends in pharmacological sciences.

[33]  A. Gilman.  G proteins and regulation of adenylyl cyclase , 1989 .

[34]  J. Daly,et al.  ADENOSINE 3′,5′‐MONOPHOSPHATE IN GUINEA PIG CEREBRAL CORTICAL SLICES: EFFECTS OF α‐ AND β‐ADRENERGIC AGENTS, HISTAMINE, SEROTONIN AND ADENOSINE , 1973 .

[35]  R. Leurs,et al.  Inverse agonism of histamine H2 antagonist accounts for upregulation of spontaneously active histamine H2 receptors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Rodbell,et al.  Signal transduction: evolution of an idea. , 1995, Environmental health perspectives.

[37]  J. Black,et al.  COMPARISON OF SOME PROPERTIES OF PRONETHALOL AND PROPRANOLOL , 1997, British journal of pharmacology and chemotherapy.

[38]  Brian K. Kobilka,et al.  Cloning of the gene and cDNA for mammalian β-adrenergic receptor and homology with rhodopsin , 1986, Nature.

[39]  I. Hall,et al.  Pharmacological characterization of CGP 12177 at the human beta(2)-adrenoceptor. , 2002, British Journal of Pharmacology.

[40]  F. Marshall,et al.  GABAB receptors - the first 7TM heterodimers. , 1999, Trends in pharmacological sciences.

[41]  Robert J. Lefkowitz,et al.  Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Christopher M. Tan,et al.  Membrane trafficking of G protein-coupled receptors. , 2004, Annual review of pharmacology and toxicology.

[43]  Holger Stark,et al.  High constitutive activity of native H3 receptors regulates histamine neurons in brain , 2000, Nature.

[44]  I. Hall,et al.  Agonist and Inverse Agonist Actions of β-Blockers at the Human β2-Adrenoceptor Provide Evidence for Agonist-Directed Signaling , 2003 .

[45]  J. Black,et al.  Definition and Antagonism of Histamine H2-receptors , 1972, Nature.

[46]  R. Lefkowitz,et al.  Protein Kinase A and G Protein-coupled Receptor Kinase Phosphorylation Mediates β-1 Adrenergic Receptor Endocytosis through Different Pathways* , 2003, Journal of Biological Chemistry.

[47]  J Black,et al.  Drugs from Emasculated Hormones: The Principle of Syntopic Antagonism , 1989, Science.

[48]  J. Edwardson,et al.  Endocytosis and recycling of G protein-coupled receptors. , 1997, Trends in pharmacological sciences.

[49]  Terry Kenakin,et al.  Drug efficacy at G protein-coupled receptors. , 2002, Annual review of pharmacology and toxicology.

[50]  A. Tobin,et al.  Stimulus-dependent Phosphorylation of G-protein-coupled Receptors by Casein Kinase 1α* , 1997, The Journal of Biological Chemistry.

[51]  N. Birdsall,et al.  The binding of agonists to brain muscarinic receptors. , 1978, Molecular pharmacology.

[52]  Melanie G. Lee,et al.  RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor , 1998, Nature.

[53]  R. Lefkowitz,et al.  Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. , 1994, Science.

[54]  L. Hunyady,et al.  Independent β-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[55]  R. Lefkowitz.  Historical review: a brief history and personal retrospective of seven-transmembrane receptors. , 2004, Trends in pharmacological sciences.

[56]  Characterization of recombinant human serotonin 5HT1A receptors expressed in Chinese hamster ovary cells. [3H]spiperone discriminates between the G-protein-coupled and -uncoupled forms. , 1993, Biochemical pharmacology.

[57]  J. Drews.  Paul Ehrlich: Magister Mundi , 2004, Nature Reviews Drug Discovery.

[58]  S. Hill,et al.  G protein-coupled-receptor cross-talk: the fine-tuning of multiple receptor-signalling pathways. , 1998, Trends in pharmacological sciences.

[59]  R. Lefkowitz,et al.  The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. , 2002, Journal of cell science.

[60]  P. Insel,et al.  Colchicine potentiates β-adrenoreceptor-stimulated cyclic AMP in lymphoma cells by an action distal to the receptor , 1978, Nature.

[61]  A. Helenius,et al.  Glycan-dependent and -independent Association of Vesicular Stomatitis Virus G Protein with Calnexin* , 1996, The Journal of Biological Chemistry.

[62]  L. Iversen,et al.  Muscarinic cholinergic receptors in rat corpus striatum and regulation of guanosine cyclic 3',5'-monophosphate. , 1978, Molecular pharmacology.

[63]  S. Hill,et al.  Affinities of Histamine H1‐Antagonists in Guinea Pig Brain: Similarity of Values Determined from [3H]Mepyramine Binding and from Inhibition of a Functional Response , 1981, Journal of neurochemistry.

[64]  T. Kohout,et al.  Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization. , 2003, Molecular pharmacology.

[65]  Pascale G. Charest,et al.  β-Arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[66]  A. Tobin,et al.  Phosphorylation of the Gq/11-coupled M3-Muscarinic Receptor Is Involved in Receptor Activation of the ERK-1/2 Mitogen-activated Protein Kinase Pathway* , 2001, The Journal of Biological Chemistry.

[67]  Mark H Ellisman,et al.  A FlAsH-based FRET approach to determine G protein–coupled receptor activation in living cells , 2005, Nature Methods.

[68]  P. Leff,et al.  Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. , 1998, Molecular pharmacology.

[69]  C. Carman,et al.  G-protein-coupled receptors: turn-ons and turn-offs , 1998, Current Opinion in Neurobiology.

[70]  H. Bourne,et al.  Histamine Augments Leukocyte Adenosine 3',5'-Monophosphate and Blocks Antigenic Histamine Release , 1971, Science.

[71]  D. Kendall,et al.  Inositol Phospholipid Hydrolysis in Rat Cerebral Cortical Slices: I. Receptor Characterisation , 1984, Journal of neurochemistry.

[72]  S. Hill,et al.  Clathrin‐independent internalization of the human histamine H1‐receptor in CHO‐K1 cells , 2005, British journal of pharmacology.

[73]  S. Hill,et al.  Specific binding of 3H-mepyramine to histamine H1 receptors in intestinal smooth muscle , 1977, Nature.

[74]  F. Ciruela,et al.  Involvement of caveolin in ligand-induced recruitment and internalization of A(1) adenosine receptor and adenosine deaminase in an epithelial cell line. , 2001, Molecular pharmacology.

[75]  T. Kenakin,et al.  Inverse, protean, and ligand‐selective agonism: matters of receptor conformation , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[76]  Lakshmi A. Devi,et al.  G-protein-coupled receptor heterodimerization modulates receptor function , 1999, Nature.

[77]  S. Lazareno,et al.  Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity. , 2004, Molecular pharmacology.

[78]  J. Schwartz,et al.  Protean agonism at histamine H3 receptors in vitro and in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.